Insider Transactions in Q3 2024 at Vera Therapeutics, Inc. (VERA)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 25
2024
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
23,125
-0.67%
|
$1,063,750
$46.19 P/Share
|
|
Sep 25
2024
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,125
+0.66%
|
$46,250
$2.9 P/Share
|
|
Sep 19
2024
|
Beth C Seidenberg |
SELL
Open market or private sale
|
Direct |
13,823
-8.62%
|
$580,566
$42.31 P/Share
|
|
Sep 18
2024
|
Beth C Seidenberg |
SELL
Open market or private sale
|
Indirect |
1,476
-26.9%
|
$61,992
$42.0 P/Share
|
|
Sep 18
2024
|
Beth C Seidenberg |
SELL
Open market or private sale
|
Direct |
1,177
-0.73%
|
$49,434
$42.01 P/Share
|
|
Sep 11
2024
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
15,625
-2.47%
|
$578,125
$37.55 P/Share
|
|
Sep 11
2024
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,625
+2.41%
|
$31,250
$2.9 P/Share
|
|
Aug 28
2024
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
30,320
-2.3%
|
$1,121,840
$37.17 P/Share
|
|
Aug 28
2024
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,625
+2.22%
|
$31,250
$2.9 P/Share
|
|
Aug 21
2024
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
14,471
-4.29%
|
$564,369
$39.76 P/Share
|
|
Aug 14
2024
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
15,625
-4.43%
|
$578,125
$37.56 P/Share
|
|
Aug 14
2024
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,625
+4.24%
|
$31,250
$2.9 P/Share
|